2nd Quarter - Report

SEQIRUS for SEQIRUS

Period 2nd Quarter 2025 Filed Jul 21, 2025 Signed by James Sherner

Official filing
Firm
SEQIRUS
Client
SEQIRUS
Income
—
Expenses
$260,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY2025 and FY2026 Appropriations, policies related to pandemic preparedness, public health, and influenza preparedness; H.R. 3838/S. 2296, FY2026 NDAA, policies related to pandemic preparedness, public health, and influenza preparedness;

Foreign entity interest: CSL Limited, identified on Registration (LD-1), is the parent company of Seqirus and benefits from the financial success thereof.

LobbyistCovered position, as disclosed
CHRISTINE FARQUHARSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3838 (119th), S. 2296 (119th)

Health Issues HCR

FY2025 and FY2026 Appropriations, policies related to pandemic preparedness, public health, and influenza preparedness; H.R. 3838/S. 2296, FY2026 NDAA, policies related to pandemic preparedness, public health, and influenza preparedness;

Foreign entity interest: CSL Limited, identified on Registration (LD-1), is the parent company of Seqirus and benefits from the financial success thereof.

LobbyistCovered position, as disclosed
CHRISTINE FARQUHARSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3838 (119th), S. 2296 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.